Ondansetron solution for injection

Country: Armenia

Language: English

Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Active ingredient:

ondansetron (ondansetron hydrochloride dihydrate)

Available from:

Lekhim-Kharkiv PrJSC

ATC code:

A04AA01

INN (International Name):

ondansetron (ondansetron hydrochloride dihydrate)

Dosage:

2mg/ml

Pharmaceutical form:

solution for injection

Units in package:

(5) ampoules 4ml, (5/1x5/) ampoules 4ml in blister

Prescription type:

Prescription

Authorization status:

Registered

Authorization date:

2017-11-30

Patient Information leaflet

TIHCTPYKIIUS
noMeAI{uHHcKolwynpHMeHeHItX}neKapcTBeHllorocpeAcTBa
oTTAAHCETPOH
(ONDANSETRON)
Cocmae:
d
eilcmeynrye
e
Bet4e
cm6o.'
onAaucerpou;
I
ur
pacrnopa
corepxr,rr
0,002
r
oHAaHcerpoua
(u
BHAe
oHAaHCerpoHa
rH,[poxJloprnxa
nrana.qpara);
*cn,I.ozameJrbHue
eeu4ecms7.'
KI.ISJIOTa
JIHMoHHat
MoHorHApaT,
HaTpHq
IIHTpaT'
HaTp![t
xJIopI4A'
BoAa.IJIff
sulerllnfl-
JlerapcrreuHaff
$opnra.
Pacmop
Als
prHreruufi'
ocaoeHue
Qusurco-xumuqecKue
ceoilcmea:
fipo3paqHar
oecqserHat
x]rAKocrb'
npaKTI'IqeCKI'r
He
coAepxnT
Mexaul4qecrnx
npuueceft
.
OapuaxorepaneBTgqecgaff
rpysra.
flpotmoproTub]e
cpeAcTBa
H
[pe[apaTbl'
ycTpautrcIque
rorrrHory.
Anraronracru
peqerropo"
r"po"o*ttu
(sHrr).
onaatlcetpon'
Kog
ATX
A04A
A01'
(D
apnaxonoeuq
ec
K
u
e cao
rtcme
a
(DapaaxoduHatvtuKa.
ongauce.rpoH
-
cr,rJrbuogefictayrournfi
Bbrcorocerexflaensrfi
anTaroHnct
5HT3
(cepotolllrnonrx)
perrenrodB.
flpenapar
upeA)mpexAaer
vltvt
ycrparuler
Tolugory
H
pBory'
BbI3bIBEFMbre
u"tot.*t""ecnofi
*t*"ot"punueft
ulunu
lyreaofi
tepanneft,
a
TaKxe
nocJleo''epaq,no*gble
TOTtrHOTy
H
pBoTy.
Mexanlrsh,l
Aeficrsus
OfiJIaHceTpOHa
AO
Kogqa
He
BbItcHeH'
BO3MoXHO'
,rp"nupur
onorupyer
BoSHUKHOBeHI,IS
pBOTHOIO
pe$lerca,
npotBJltfl
aHTaroHI{cTUqecKoe
AeEcrene
oTHocHTerrbrro
5HTt-peuenTopoB,
JIOKaJII{3yIOUHXC'
r
nefipoHax
rar
nepuQepn'recroft',
TAK
g
llerrTpairbrrofi
Hepnuofi
cncrer"ru.
flpenapat
He
cHI{xaeT
[cI'IxoMoTopHyIo
aKTUBHOCTb
narIHeHTa
H
lre
oKa3blBaer
ceAarllBlroro
sSi[exra'
@apaaxarcuHemuKa.
I1pr,l
nxytptrMbrureqHoM
BBeAeHI,II.I
MaKcI,lMatIbHaJI
KOHUeHTpaUut
B
nJIa3Me
KpoBr{
AocTuraeTct
B
,*.r""r"
10
*"ryr.
o6seM
pacnpeAeJreHlrfl
rrocJle
napenrepaJlbHoro
BBeAeIrUt
y
B3pOCiIbIX
cocraBJrfier
l40.ir.
Ocnosnar
rracrb
eseAeHgoft
Ao3bI
r,reta6onns{pyerct
B
IIeqeHLr'
C
}ro'roft
s
Her{3MeHeHr{oM
Brd.qe
BbIBo,AI4Tce
Megee
5
7o
npenapam.
flepraO,U,
ngnyBblBege;gvfl
-
OKOJIO
3
"IaCOS
(y
6onrnrx
noxr,uroro
Bo3pacTa-
5
.racoe).
ceg351Bagge
c
fie;1aug
IIJIAnM6I
-70-76%'
y
naquesroB
c
.Iloqe,rsofi
HeAOCTaTOT{lIocTbro
cpegnefi
cTeneHH
(rnnpenc
KpeaT}rHEHa
15-
60
rran/u*r)
yueururarorcr

Summary of Product characteristics

61
06 rrlA.fl
XAPAKTEPnCTI{KA
JTEKAPCTBEHHOTO
CPEACTBA
1.
Haseanue neKapetneevfioeo
cpelcmea:
OnAancerpon
pacrBop.rurfl
nnrercqnft 2
rarlmn, no
2
un
r,rJru
no 4
un
B
aMrryJrax
2, Koraecmaeftnotfi
u
KoJtaqecmsewnwrt cocmae:
deilcmeytottrye
6et4e
cm6o
:
an&ancerpon;
I
un
pacrropa
coAepxcnT
0,002
r
ouAancerpoHa
(n
nfi.[e
oH.(ancerpona rugpoxnopnra
auru.npara);
Banon4ozamenbHbre
6eulecmga.'
KlrcJIoTa
JMMOHHafl
MOHOrH.4paT,
xJropI{A,
BoAa,(nt
nurexuptft.
,
:i..:
HaTpHr
rIHTpaT)
Ha'rpfit
3.
Jlexapcmnewnon
Qopwa:
Pacmop
Ans
Hurerultft.
4.
Ihwnurtecnan unfiop,uaqun:
4.
I
.
TepaaeemuvecKue noKtriaHufr.
i:il:i]ill,',1
r!
!
'
|
.
,.
!i
i
I
.t,1.1t.;1,1i
a-8
//,e
''a1r'/r'r-
Tomnora
H
pBora,
Bb$BarrHbre
ur{ToroKcr{.recrofi
xnMnorepannefi
lt
ryrenofi
repanneft.
IlpoSanamnKa
H
rer{ense
nocJreouepaqfiorrHoft
rorunoru
r,r
pBorbr.
4.
2.
Cnoco6
npuneaeuua.
Tow\ama
u
peoma.
aaseauuwe
Eu*tuomepanueil
q
n])yeeoil
mepantleit.
Sverorennufi
norenunarr
repanlau
paKa
Bapbupyer
B
3aBucrlMocrr,r
or
.uo3br
H
xorvt6nnaIlnx
pexuMoB
xr{Muorepa[Hu
n
nyreeofi
Tepanur{.
Bsr6op
pe)KaMa
,uo3}rpoBaunc
3aBscur
or
Tffxecrr.r
gMeroregHoro
eosAeft
crBl{t.
Bspocrue.
Saemo?eiluan xutuuomepanua
u
nyqegan
mepanua.
PexoueH,uyeMaff
Bnyrpr.rBeHHar
Hnr,r Buyrpr,rMbrrrreqnar
aoga
OHgaHcerpoHa
-
I
ur
B
BHAe
ueArenHofi
r,rHbeKrIHH
BTeqeHne
He
MeHee
.{eru
30
ceKyHA, HenocpeAcrBeHno
nepeA
JreqeH}IeM.
Arg
npoQra.rraxraxra
orcpovenuoft
,rfiu
Arurenrsoft
pnorbr
nocJre
fiepBbrx
24
qacoB
peKoMeH.{yercfl
flepopaJrbHoe
HJrr4
peKT{urbHoe
np}rMeHeHHe
npenapara.
Bwc
o
rc
o
an
e
m
o
z
en
x
as
xuu
uo
me
p
anun
(u
anpwt
e
p
epi
o rcu
e
d o
sw
uuc
Wamuuql.
OHlaucerpon
Molr(Ho
Ha3r{aqarb
B
BHAe
oAHorpatnofi
A0361
8
ur
BHyrpr.rBeHHo
,rrw
Bnylpr4Mbrilreqno Heflocpe/tcrBer{Ho
[epe4
xnMrrorepannefi.
.{orsr
6oree
8
ur
(ao
16
rrr)
MolKHo
nplrMexffrb
roJrbro
B
Br,rAe
BHyrpHBeHHoft
uH{pr4v
Ha
50-l00u.n
0o9olo
pacrnopa
Harpnr
xJropuAa
HJII{
Apyrofo
coorBercrBllouero
pacrBopr.rreJrr
(crvr.
Hnxe);
uxSyrur
AoJrxHa
Am{Tbcs
He Merree
15
uuxyr.
Oguopasonya
Ao3,
npeBbrruapuryrc
16
Mr,
npr,rMeHsrb